Navigation Links
Jivan Focuses on Solutions for Transcriptome Sequencing
Date:4/9/2009

LARKSPUR, Calif., April 9 /PRNewswire/ -- Jivan announced today that it will provide bioinformatics solutions for high-throughput transcriptome sequencing (RNA-Seq) and expression. Leveraging Jivan's industry-leading bioinformatics infrastructure for analysis of mRNA in biological samples, Jivan will provide "bioinformatics for the next generation." Jivan will offer content for targeted sequencing with mRNA capture arrays, mRNA specific PCR primer designs for targeted amplification, and software for analyzing mRNA expression from RNA-Seq, multiplexed PCR and microarrays.

"Jivan is uniquely situated to address the informatics challenges of transcriptome sequencing," said Subha Srinivasan, PhD, CEO of Jivan. "Our mRNA sequence databases, software infrastructure, oligonucleotide design capabilities, and expression analysis software give us a tremendous advantage in developing solutions for RNA sequencing."

Jivan has developed a database for analysis of mRNA expression from transcriptome sequencing. It enables advanced expression counts that go beyond the basic reads per kilo base (rpkb) that is the current standard.

To support RNA sequencing, Jivan's technology offering will include mRNA Capture Arrays for targeted sequencing of genomes, gene families and therapeutic areas. By using Jivan's database of mRNA sequences, including exons and exon junctions, Jivan can ensure the capture of all mRNA sequences of each gene of interest, including wildtype transcripts and splice variants. For genes or mRNAs with low expression, Jivan will offer mRNA Prime(TM) PCR primer designs specific to each observed mRNA.

To analyze RNA sequencing data, Jivan will offer a software tool called mRNA Magic(TM) that provides functionality for sophisticated expression analysis from sequence reads.

For more information, see http://www.jivanbio.com.

About Jivan

Jivan empowers scientists with new insight by providing a full range of products and services for mRNA sequencing and expression, including capture arrays, PCR primers and amplicons, and transcriptome sequencing software.

    Contact:

    Jonathan Bingham
    jbingham@jivanbio.com
    +1 415 425 4115

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Jivan Biologics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Jivan Awarded US Patent #7,340,349 for Splice Array Analysis
2. International Scientific Workshop Focuses on New Methods for Vaccine and Antibody Development
3. GPhA Annual Meeting Focuses on Industry Opportunities and Challenges for 2008
4. Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs
5. Global Stem Cell Forum in China Showcases Cutting Edge Research, Focuses on New Findings for iPS Cells
6. New Initiative Focuses on Water Quality Improvement in the Mississippi River Basin and Gulf of Mexico
7. ECBCs Environmental BioMonitoring Laboratory Focuses on the Future
8. Clinical Research Study Focuses on Little Known Behavioral Changes Related to Parkinsons Disease
9. Siemens Focuses on Role-Based, Context-Sensitive, and Knowledge-Driven Solutions at HIMSS 2009
10. ImQuest Presentation at Keystone Symposium Focuses on Advancements in Their Cancer Research and Development Program
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... CA (PRWEB) , ... June 23, 2016 , ... ... software, is exhibiting at the Pennsylvania Convention Center and will showcase its product’s ... conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials ...
(Date:6/23/2016)... 2016 ReportsnReports.com adds 2016 ... its pharmaceuticals section with historic and forecast data ... more. Complete report on the Cell ... 15 companies and supported with 261 tables and ... . The Global Cell Culture Media ...
Breaking Biology Technology:
(Date:5/12/2016)... 2016 WearablesResearch.com , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
Breaking Biology News(10 mins):